1. Systemic therapy of hepatocellular carcinoma: Are we making progress?

   • Patricia Roxburgh
   • T. R. Jeffry Evans

   Review 29 October 2008 Pages: 1089 - 1104

2. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome

   • Aleksander Krag
   • Tine Borup
   • Flemming Bendtsen

   Review 18 November 2008 Pages: 1105 - 1140

3. Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?

   • Eugen Florin Georgescu

   Review 29 October 2008 Pages: 1141 - 1174

4. Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin

   • Jules I. Schwartz
   • Stephanie Dunbar
   • John A. Wagner

   Original Research 06 November 2008 Pages: 1175 - 1190

5. Corneal staining reductions observed after treatment with Systane® Lubricant Eye Drops

   • Mike T. Christensen

   Original Research 29 October 2008 Pages: 1191 - 1199

6. Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities

   • Roger Messin
   • Claude Dubois
   • Jean-Pierre Famaey

   Original Research 10 November 2008 Pages: 1200 - 1214

7. Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia

   • Conrad Baldamus
   • Stefan Krivoshiev
   • Angelika Bronn

   Original Research 16 October 2008 Pages: 1215 - 1228

8. Evaluating the long-term effect of ultrasound-guided needle puncture without aspiration on calcifying supraspinatus tendinitis

   • Jiaan Zhu
   • Yeqing Jiang
   • Bing Hu

   Original Research 08 November 2008 Pages: 1229 - 1234